Stimulation of the beta3-Adrenoceptor as a novel treatment strategy for anxiety and depressive disorders. (Q34623015)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460614%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

Stimulation of the beta3-Adrenoceptor as a novel treatment strategy for anxiety and depressive disorders (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460614%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460614%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

11

Stephen M Stahl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460614%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Jeanne Stemmelin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460614%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Caroline Cohen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460614%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Jean-Paul Terranova

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460614%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Matilde Lopez-Grancha

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460614%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Philippe Pichat

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460614%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Olivier Bergis

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460614%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Michel Decobert

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460614%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Vincent Santucci

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460614%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Dominique Françon

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460614%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Richard Alonso

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460614%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Peter Keane

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460614%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Patrick Avenet

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460614%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Bernard Scatton

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460614%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Gérard le Fur

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460614%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

language of work or name

English

0 references

publication date

25 April 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460614%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

published in

Neuropsychopharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460614%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460614%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

574-587

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460614%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460614%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.npp.1301424

29 December 2019

exact match

0 references

cites work

Effects of L-tryptophan and other amino acids on electroencephalographic sleep in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301424

In vitro inhibition of intestinal motility by phenylethanolaminotetralines: evidence of atypical beta-adrenoceptors in rat colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301424

Differentiation of anxiolytic and panicolytic drugs by effects on rat and mouse defense test batteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301424

A new method for rapid screening of minor tranquillizers in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301424

Modulatory effects of norepinephrine in the lateral bed nucleus of the stria terminalis on behavioral and neuroendocrine responses to acute stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301424

Ethopharmacological analysis of rat behavior on the elevated plus-maze.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301424

Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301424

A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301424

Diazepam and nicotine increase social interaction in gerbils: a test for anxiolytic action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301424

Beta-adrenergic receptors are involved in stress-related behavioral changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301424

Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301424

Adrenergic receptor function in panic disorder. II. Neutrophil beta 2 receptors: Gs protein coupling, effects of imipramine treatment and relationship to treatment outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301424

Agonist interactions with beta-adrenergic receptors following chronic administration of desipramine or the atypical antidepressants, iprindole and mianserin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301424

Effect of chronic antidepressant treatment on beta-receptor coupled signal transduction cascade. Which effect matters most?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301424

Activation of beta2- and beta3-adrenergic receptors increases brain tryptophan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301424

A new test for aggression in rats without aversive stimulation: Differential effects of d-amphetamine and cocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301424

Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301424

Developments of a water-maze procedure for studying spatial learning in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301424

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301424

Depression: a new animal model sensitive to antidepressant treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301424

Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301424

Evidence for the presence of beta 3-adrenergic receptor mRNA in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301424

Selective blockade of NK2 or NK3 receptors produces anxiolytic- and antidepressant-like effects in gerbils

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301424

Effect of pharmacologic treatments on the sleep of depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301424

Structure and function of the beta 3-adrenergic receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301424

Expression of beta 3-adrenoceptor mRNA in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301424

Chronic mild stress-induced anhedonia: a realistic animal model of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301424

Stress-induced hyperthermia as a putative anxiety model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301424

4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine hydrochloride (SSR125543A), a potent and selective corticotrophin-releasing factor(1) receptor antagonist. II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301424

7 January 2021

Further heterogeneity of the beta-adrenoceptor. The phenylethanolaminotetralines: new selective agonists for atypical beta-adrenoceptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301424

7 January 2021

Dual aminergic regulation of central beta adrenoceptors. Effect of "atypical" antidepressants and 5-hydroxytryptophan

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301424

7 January 2021

Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301424

7 January 2021

Targeted gene disruption reveals a leptin-independent role for the mouse beta3-adrenoceptor in the regulation of body composition.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301424

7 January 2021

Antidepressant profile in rodents of SR 58611A, a new selective agonist for atypical beta-adrenoceptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301424

7 January 2021

Function and regulation of the beta 3-adrenoceptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301424

7 January 2021

Pharmacological evaluation of a modified conflict procedure: punished drinking in non-water-deprived rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301424

7 January 2021

A simple and reliable conflict procedure for testing anti-anxiety agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301424

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1301424

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460614%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

29 December 2019

0 references

1 reference